NCT02262624View on ClinicalTrials.gov

Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

February 28, 2005

Conditions
Healthy
Interventions
DRUG

Telmisartan

DRUG

Hydrochlorthiazide (HCTZ)

DRUG

Telmisartan/HCTZ fixed combination

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY